All questionsPharmacology: Tremfya (guselkumab), all indications5 questions · 3 sourcesMechanismHow does Tremfya work (mechanism of action)?“Guselkumab is a human monoclonal IgG1λ antibody that selectively binds to the p19 subunit of interleukin 23 (IL-23) and inhibits its interaction with the IL-23 receptor. IL-23 is a naturally occurring cytokine that is involved in normal inflammatory and immune responses. Guselkumab inhibits the release of proinflammatory cytokines and chemokines.” (opens the source at this quote in a new tab)CopyFlag“Interaction between IL-23 and its receptor drives the differentiation, proliferation, and survival of Th17 cells” (opens the source at this quote in a new tab)CopyFlagOn the page, select: MOADoes Tremfya bind to CD64?“Blocking IL-23, a cytokine responsible for inflammation Binding to CD64, a receptor on cells that produce IL-23 The clinical significance of these findings is unknown.” (opens the source at this quote in a new tab)CopyFlag“Findings for dual-acting are limited to in vitro studies that demonstrated guselkumab's binding to CD64 in an inflammatory monocyte model.” (opens the source at this quote in a new tab)CopyFlagPharmacokineticsHow is Tremfya metabolized?“The exact pathway through which guselkumab is metabolized has not been characterized. As a human IgG monoclonal antibody, guselkumab is expected to be degraded into small peptides and amino acids via catabolic pathways in the same manner as endogenous IgG.” (opens the source at this quote in a new tab)CopyFlagHow quickly does Tremfya reach peak levels after injection?“Following a single 100 mg subcutaneous injection in healthy adult subjects, guselkumab reached a mean (± SD) maximum serum concentration of 8.09 ± 3.68 mcg/mL by approximately 5.5 days post dose. The absolute bioavailability of guselkumab following a single 100 mg subcutaneous injection was estimated to be approximately 49% in healthy adult subjects.” (opens the source at this quote in a new tab)CopyFlagComponentsWhat are the inactive ingredients in Tremfya?“TREMFYA® (guselkumab) injection is a sterile, preservative free, clear, and colorless to light yellow solution.” (opens the source at this quote in a new tab)CopyFlag“Each TREMFYA 1 mL prefilled syringe, prefilled pen (TREMFYA PEN), or One-Press patient-controlled injector delivers 100 mg guselkumab, L-histidine (0.6 mg), L-histidine monohydrochloride monohydrate (1.5 mg), polysorbate 80 (0.5 mg), sucrose (79 mg) and water for injection at pH 5.8.” (opens the source at this quote in a new tab)CopyFlag